Blockade of renin-angiotensin system: A supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 767-772

  Dai, Shi mo ^a   Zhang, Shu ^a   Chu, Jian min ^a   Guo, Ying hua ^a   Chen, Ke ping ^a   Yao, Shu yuan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; TRANDOLAPRIL;

ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG DOSE TITRATION; ELECTROCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; PAROXYSMAL TACHYCARDIA; PRIORITY JOURNAL; PULMONARY VEIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; HUMANS; INDOLES; MODELS, BIOLOGICAL; PULMONARY VEINS; RENIN-ANGIOTENSIN SYSTEM;

EID: 34547924089     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.016     Document Type: Article

References (45)

1. Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
2. Haissaguerre M., Shah D.C., Jais P., et al. Electrophysiologic breakthroughs from the left atrium to the pulmonary veins. Circulation 102 (2000) 2463-2465
3. Haissaguerre M., Jais P., Shah D.C., et al. Electrophysiological endpoint for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101 (2000) 1409-1417
4. Ouyang F., Bansch D., Ernst S., et al. Complete isolation of left atrium surrounding the pulmonary veins. New insights from the double Lasso technique in paroxysmal atrial fibrillation. Circulation 110 (2004) 2090-2096
5. Schmitt C., Deisenhofez I., Schzeieck J., et al. Symptomatic and asymtomatic recurrence of atrial fibrillation after ablation:Randomized comparison of segmental pulmonary vein ablation with circumferential pulmonary vein ablation (J). Eur Heart J 25 Suppl. (2004) 277
6. Oral H., Knight B.P., Tada H., et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105 9 (2002) 1077-1081
7. Kanagaratnam L., Tomassoni G., Schweikert R., et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term followup. Pacing Clin Electrophysiol 24 12 (2001) 1774-1779
8. Nademanee K., McKenzie J., Kosar E., et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J A College Cardiol 43 11 (2004) 2044-2053
9. Haissaguerre M., Sanders P., Hocini M., et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol 16 11 (2005) 1125-1137
10. Jais P., Hocini M., Hsu L.F., et al. Technique and results of linear ablation at the mitral isthmus. Circulation 110 19 (2004) 2996-3002
11. Pappone C., Santinelli V., Manguso F., et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109 3 (2004) 327-334 cardiac autonomic denervation
12. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north scandinavian enalapril survival study. N Engl J Med 316: p. 1429-35.
13. The SOLVD investigators effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325: p. 293-303.
14. Kjekshus J, Swedberg K. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north scandinavian enalapril survival study (CONSENSUS). Am J Cardiol 62: p. 60A-66A.
15. Kober L., Torp-Pedersen C., Carlsen J.E., et al. For the trandolapril cardiac evaluation (TRACE) study group a clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 333 (1995) 1670-1676
16. Hamabe A., Okuyama Y., Miyauchi Y., et al. Correlation between anatomy and electrical activation in canine pulmonary veins. Circulation 107 (2003) 1550-1555
17. Brilla C.G., Zhou G., Matsubara L., and Weber K.T. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26 (1994) 809-820
18. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35: 1669-1677.
19. Danshi L., Fnreh S., Leung T.K., et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodelling of a different sort. Circulation 100 (1999) 87-95
20. Wijffells M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
21. Nattel S., and Li D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87 (2000) 440-447
22. Mark D.O., and Pierre J.Y. Takahashi the stepwise ablation approach for chronic atrial fibrillation-evidence for a cumulative effect. J Interv Card Electrophysiol 16 (2006) 153-167
23. Nakashima H., Kumagai K., Urata H., et al. Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation. Circulation 101 (2000) 2612-2617
24. + currents. Circulation 101 (2000) 1199-1205
25. Riyako S., Kojiro N., Satoki F., et al. Angiotensin-converting enzyme inhibitor suppresses the incidence of prolonged and fractionated right atrial electrograms. PACE 29 (2006) 164-170
26. Shi Y., Li D., Tardif J.C., et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 54 (2002) 456-461
27. Yu W.C., Lin Y.K., Tai C.T., et al. Early recurrence of atrial fibrillation after external cardioversion. Pacing Clin Electrophysiol 22 11 (1999) 1614-1619
28. Tse H.F., Lau C.P., and Ayers G.M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart 82 3 (1999) 319-324
29. Lammers W.J., Schalij M.J., Kirchhof C.J., et al. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol 259 4 Pt 2 (1990) H1254-H1263
30. Wang J., Liu L., Feng J., and Nattel S. Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. Am J Physiol 271 1 Pt 2 (1996) H148-H158
31. Chen S.A., Hsieh M.H., Tai C.T., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radio frequency ablation. Circulation 100 18 (1999) 1879-1886
32. Tsai C.F., Tai C.T., Hsieh M.H., et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radio frequency ablation. Circulation 102 1 (2000) 67-74
33. Dibner-Dunlap M.E., Smith M.L., Kinugawa T., et al. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 27 2 (1996) 358-364
34. Lombardi F., Colombo A., Basilico B., et al. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol 37 1 (2001) 157-162
35. Chen Y.J., Chen S.A., Chen Y.C., et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation 104 23 (2001) 2849-2854
36. Touyz R.M., Sventek P., Lariviere R., et al. Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27 5 (1996) 1090-1096
37. 2+ exchange to action potential of human atrial myocytes. Am J Physiol 271 3 Pt 2 (1996) H1151-H1161
38. Webster M.W., Fitzpatrick M.A., Nicholls M.G., et al. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol 56 8 (1985) 566-569
39. Ueng K.C., Tsai T.P., Yu W.C., et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation:results of a prospective and controlled study. Eur Heart J 24 (2003) 2090-2098
40. Yanfen S., Anique D., Danshi L., et al. Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52 (2001) 217-225
41. Cardin S., Thorin-Trescases N., Leung T.K., et al. Evolution of the atrial substrate in experimental heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60 (2003) 315-325
42. Anique D., Karl S., Marc A.P., et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J 152 (2006) 86-92
43. Kristian W., and Mika L. Eva gerdtset al angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol. J Am Coll Cardiol 45 (2005) 712-719
44. Zaman A.G., Kearney M.T., Schecter C., et al. Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J 147 (2004) 823-827
45. Roberto F., Amedeo M., Maurizio D., et al. Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol TM 47 (2006) 46-50